Sign inGet started

Colowick Alan

Insider CIK 1316163 · AKAO Director · PRNB Director · PSNL Director · DMTX Director · HARP Director · ALMS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALMS ALUMIS INC. P Buy2025-04-022025-04-032,300$7.49 $17.2K18,404SEC↗
ALMS ALUMIS INC. P Buy2025-04-012025-04-0316,104$6.97 $112.2K16,104SEC↗
PSNL Personalis, Inc. A Award deriv2023-05-172023-05-1940,000— $040,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award2023-04-012023-04-0416,456— $016,456SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2022-06-222022-06-2428,571$1.40 $40.0K28,571SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2022-06-222022-06-2410,167— $010,167SEC↗
PSNL Personalis, Inc. A Award deriv2022-05-172022-05-1915,035— $015,035SEC↗
PSNL Personalis, Inc. A Award2022-05-172022-05-1910,770— $013,506SEC↗
PSNL Personalis, Inc. A Award deriv2021-05-142021-05-184,229— $04,229SEC↗
PSNL Personalis, Inc. A Award2021-05-142021-05-182,736— $02,736SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2021-05-042021-05-0710,167— $010,167SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2021-03-242021-03-2620,335— $020,335SEC↗
PRNB Principia Biopharma Inc. D To issuer deriv2020-09-282020-09-2810,240— $00SEC↗
PRNB Principia Biopharma Inc. D To issuer deriv2020-09-282020-09-2810,240— $00SEC↗
PRNB Principia Biopharma Inc. D To issuer deriv2020-09-282020-09-2847,724— $00SEC↗
PRNB Principia Biopharma Inc. D To issuer deriv2020-09-282020-09-2820,475— $00SEC↗
PRNB Principia Biopharma Inc. M Exercise deriv2020-07-012020-07-027,500— $047,724SEC↗
PRNB Principia Biopharma Inc. M Exercise2020-07-012020-07-027,500$4.54 $34.0K7,500SEC↗
PRNB Principia Biopharma Inc. S Sale2020-07-012020-07-027,500$60.00 $450.0K0SEC↗
PRNB Principia Biopharma Inc. A Award deriv2020-06-042020-06-0810,240— $010,240SEC↗
PSNL Personalis, Inc. A Award deriv2020-05-152020-05-1914,000— $014,000SEC↗
PRNB Principia Biopharma Inc. M Exercise deriv2020-05-052020-05-056,660— $055,224SEC↗
PRNB Principia Biopharma Inc. S Sale2020-05-052020-05-056,660$60.00 $399.6K0SEC↗
PRNB Principia Biopharma Inc. M Exercise2020-05-052020-05-056,660$4.54 $30.2K6,660SEC↗
PRNB Principia Biopharma Inc. M Exercise deriv2020-05-012020-05-05840— $061,884SEC↗
PRNB Principia Biopharma Inc. S Sale2020-05-012020-05-05840$60.07 $50.5K0SEC↗
PRNB Principia Biopharma Inc. M Exercise2020-05-012020-05-05840$4.54 $3.8K840SEC↗
PRNB Principia Biopharma Inc. A Award deriv2019-06-112019-06-1110,240— $010,240SEC↗
PRNB Principia Biopharma Inc. A Award deriv2018-09-132019-01-1020,475— $020,475SEC↗
DMTX Dimension Therapeutics, In D To issuer deriv2017-11-072017-11-0744,474— $00SEC↗
DMTX Dimension Therapeutics, In D To issuer deriv2017-11-072017-11-0732,069— $00SEC↗
DMTX Dimension Therapeutics, In D To issuer deriv2017-11-072017-11-0717,000— $00SEC↗
AKAO Achaogen Inc A Award deriv2017-06-142017-06-1610,000— $010,000SEC↗
DMTX Dimension Therapeutics, In A Award deriv2017-05-252017-05-2617,000— $017,000SEC↗
AKAO Achaogen Inc A Award deriv2016-06-152016-06-1710,000— $010,000SEC↗
DMTX Dimension Therapeutics, In A Award deriv2016-05-192016-05-2332,069— $032,069SEC↗
AKAO Achaogen Inc A Award deriv2015-03-112015-03-1320,000— $020,000SEC↗